Clinical Trial: Sotoclaro combined with R-CHOP regimen for the treatment of newly diagnosed aggressive B-cell lymphoma with BCL2 positivity: A multicenter, single-arm, open-label Ib/II phase clinical study (China)

Posted On: 2026-09-07

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Sotoclaro combined with R-CHOP regimen for the treatment of newly diagnosed aggressive B-cell lymphoma with BCL2 positivity: A multicenter, single-arm, open-label Ib/II phase clinical study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131616

Registration Time: 2026/09/04

Type: Interventional study

Primary Sponsor: Zhujiang Hospital of Southern Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339534

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Sotoclaro combined with R-CHOP regimen for the treatment of newly diagnosed aggressive B-cell lymphoma with BCL2 positivity: A multicenter, single-arm, open-label Ib/II phase clinical study (China)